Cel-Sci Corporation (CVM) Financial Statements (2024 and earlier)

Company Profile

Business Address 8229 BOONE BLVD .
VIENNA, VA 22182
State of Incorp. CO
Fiscal Year End September 30
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
MRQ
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2019
9/30/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 25022,67242,21215,5098,44510,310
Cash and cash equivalents 25022,67236,06015,5098,44510,310
Short-term investments   6,151   
Receivables   555563119
Inventory, net of allowances, customer advances and progress billings2,2482,0022,007820782645
Inventory2,2482,0022,007820782645
Prepaid expense5207629981,313525365
Deposits current assets4     
Other undisclosed current assets3,896     
Total current assets:6,91825,43645,27217,6979,81511,439
Noncurrent Assets
Inventory, Noncurrent 75164    
Finance lease, right-of-use asset, after accumulated amortization9,13210,93812,69213,812 
Operating lease, right-of-use asset1,6981,8842,0561,199 
Property, plant and equipment10,18811,88913,6645,84415,82616,219
Intangible assets, net (including goodwill)198212276313312258
Intangible assets, net (excluding goodwill)198212276313312258
Deposits noncurrent assets 2,319     
Other undisclosed noncurrent assets  1,911(19,468)1,6711,671
Total noncurrent assets:23,61025,08830,5981,70017,80818,148
Other undisclosed assets    21,139  
TOTAL ASSETS:30,52850,52475,87040,53627,62329,586
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,0592,4612,5352,5341,6215,949
Accounts payable2,0101,6181,6762,0231,5865,744
Accrued liabilities1,05084285951134205
Debt1,772     
Derivative instruments and hedges, liabilities   4372146742,499
Other liabilities     1514
Due to related parties471266448709765
Other undisclosed current liabilities7551,7316991,070  
Total current liabilities:5,5864,6643,9374,2663,0209,227
Noncurrent Liabilities
Long-term debt and lease obligation9,95013,57215,27412,867  
Finance lease, liability9,95011,72113,25211,753 
Liabilities, other than long-term debt1,7781251253,6775,8366,852
Other liabilities1251251251252333
Operating lease, liability1,6531,8502,0211,114 
Derivative instruments and hedges, liabilities    3,5525,8146,818
Other undisclosed noncurrent liabilities     13,63313,507
Total noncurrent liabilities:11,72813,69715,39916,54419,47020,359
Total liabilities:17,31318,36019,33620,81022,48929,586
Equity
Equity, attributable to parent13,21532,16356,53419,7275,1341
Common stock474434432387352280
Additional paid in capital499,832486,626474,299401,175358,508331,312
Accumulated deficit(487,091)(454,897)(418,196)(381,835)(353,726)(331,592)
Total equity:13,21532,16356,53419,7275,1341
TOTAL LIABILITIES AND EQUITY:30,52850,52475,87040,53627,62329,586

Income Statement (P&L) ($ in thousands)

12/31/2023
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2019
9/30/2018
Revenues
(Other Income)
    5597371
Gross profit:    5597371
Operating expenses(31,476)(36,063)(36,194)(29,544)(20,658)(17,249)
Other undisclosed operating income     390406
Operating loss:(31,476)(36,063)(36,194)(28,985)(20,195)(16,772)
Nonoperating income (expense)(43)771,677926546 
Investment income, nonoperating  (30)1,685888546 
Other nonoperating income (expense)(43)107(8)39  
Interest and debt expense (675)  (1,200) (291)
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before equity method investments, income taxes:(32,194)(35,986)(34,517)(29,259)(19,650)(17,063)
Other undisclosed loss from continuing operations before income taxes    (997)  
Loss from continuing operations:(32,194)(35,986)(34,517)(30,255)(19,650)(17,063)
Loss before gain (loss) on sale of properties:(35,986)(34,517)(30,255)(19,650)(17,063)
Other undisclosed net income  72,687    
Net income (loss):(32,194)36,701(34,517)(30,255)(19,650)(17,063)
Other undisclosed net loss attributable to parent (73,401)(1,844) (2,485)(14,774)
Net loss attributable to parent:(32,194)(36,701)(36,361)(30,255)(22,135)(31,837)
Other undisclosed net loss available to common stockholders, basic (172)(929)(351)(22) (14)
Net loss available to common stockholders, basic:(32,366)(37,630)(36,712)(30,277)(22,135)(31,852)
Other undisclosed net loss available to common stockholders, diluted   (1,086)   
Net loss available to common stockholders, diluted:(32,366)(37,630)(37,798)(30,277)(22,135)(31,852)

Comprehensive Income ($ in thousands)

12/31/2023
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2019
9/30/2018
Net income (loss):(32,194)36,701(34,517)(30,255)(19,650)(17,063)
Comprehensive income (loss), net of tax, attributable to parent:(32,194)36,701(34,517)(30,255)(19,650)(17,063)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: